Newswise — MADISON, Wis., Aug. 1, 2016 – The Americas Committee for Treatment and Research in Multiple Sclerosis will hold its second annual conference, ACTRIMS Forum 2017, Feb. 23 – 25 at the Omni ChampionsGate in Orlando, Florida, U.S.

The focus of the 2017 forum will be environmental factors, genetics and epigenetics in multiple sclerosis susceptibility and clinical course. Forum presenters will examine current research on the relationship between diet and MS susceptibility, the effects of sex chromosomes, hormones and puberty on the risk and clinical course of MS, and the role of the microbiome in MS pathogenesis, among other topics.

The forum brings together physicians, scientists, researchers, analysts, faculty, physicians-in-training and allied health professionals to learn about the latest advances in research and treatment of MS. ACTRIMS Forum 2017 also provides unique networking opportunities with some of the top researchers in the field of MS.

ACTRIMS Forum 2016, the committee’s first standalone event, drew more than 600 researchers and clinicians to New Orleans. ACTRIMS meets triennially with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). To learn more about ACTRIMS Forum 2017, visit the event website,, and follow the event at #ACTRIMS2017.

About ACTRIMSFounded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education and collaboration among disciplines. ACTRIMS also provides a forum for experienced and newer clinicians and researchers to exchange information, debate current issues and discuss advances related to basic research and clinical issues.